Eli Lilly and Company has partnered with Nvidia to develop a powerful supercomputer aimed at accelerating drug discovery using artificial intelligence. This collaboration, announced in October and expanded in January with a $1 billion, five-year commitment, involves scientists and engineers from both companies working in a new Bay Area lab. The initiative seeks to leverage AI tools to discover new medicines, with other companies also pursuing similar AI-driven drug discovery efforts. AI
影响 Accelerates AI-driven drug discovery, potentially leading to faster development of new medicines.
排序理由 Significant collaboration between a major pharmaceutical company and a leading chip manufacturer to build AI infrastructure for drug discovery. [lever_c_demoted from significant: ic=1 ai=0.7]
在 Mastodon — fosstodon.org 阅读 →
AI 生成摘要 · Google Gemini · 来自 1 个来源。 我们如何撰写摘要 →
